Loading the records…
Loading the records…
Veterans Affairs · NAC PHARMACEUTICALS (36E797)
Veterans Affairs is planning to buy "Pantoprazole RFP". This is an early notice: it is not taking bids yet. Responses are due Dec 31, 2026. In the last 2 years, similar work went to 10 or more companies, usually for about $11.6M per award. An award is expected between December 2026 and January 2027.
Put together from the facts on this page; the details and sources are below.
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Every notice posted under solicitation 36E79727R0004 in this department, oldest first.
Standard steps for the notice type; not advice about this buyer.
ributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Glass bottles are not acceptable. Solicitation #� 36E79727R0004 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about 12/22/2026 with a tentative closing date� of 01/05/2027. The NAICS code for this procurement is� 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is� Amber Zavala. Questions can be e-mailed to:� amber.zavala@va.gov. The estimated annual requirements are as follows: Description Size Estimated Annual Requirements PANTOPRAZOLE NA 20MG TAB 90/BT 244,641 PANTOPRAZOLE NA 20MG TAB 500/BT 28,376 OR PANTOPRAZOLE NA 20MG TAB 1000/BT 14,188 PANTOPRAZOLE NA 40MG TAB 90/BT 965,273 PANTOPRAZOLE NA 40MG TAB 500/BT 237,162 OR PANTOPRAZOLE NA 40MG TAB 1000/BT 118,581
79 award notices on SAM.gov in the last 24 months. Matched by: Same office (NAC PHARMACEUTICALS (36E797)), same product/service code (PSC) 6505 and NAICS 325412.
Single-winner award sizes (79): middle half $5.1M to $25.7M, median $11.6M; range $114K to $465.4M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| GOLDEN STATE MEDICAL SUPPLY, INC. | 26 | $328.4M | Nov 12, 2026 |
| AVKARE LLC | 7 | $135.5M | Oct 26, 2026 |
| EXELAN PHARMACEUTICALS INC | 6 | $205.0M | Mar 5, 2026 |
| XLCARE PHARMACEUTICALS INC | 6 | $144.4M | Mar 9, 2026 |
| RADHA PHARMACEUTICALS INC | 6 | $69.3M | Apr 17, 2026 |
| PFIZER INC · $PFE · $63.6B | 2 | $120.9M | Apr 29, 2025 |
| SEQIRUS USA INC | 2 | $82.6M | Dec 15, 2025 |
| DR REDDY'S LABORATORIES, INC. · $RDY | 2 | $38.9M | Jan 9, 2026 |
| SOLCO HEALTHCARE US LLC | 2 | $21.5M | Jun 18, 2026 |
| MARLEX PHARMACEUTICALS INC | 2 | $10.3M | May 22, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
One award's total value against one year of revenue; many awards are paid over several years.
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.